Consequently, elevated MCP-1 levels correlate strongly with increased incidence of neuroinflammation, cognitive decline, transient ischemic attack (TIA), ischemic cerebrovascular accident (CVA), chronic renal failure, chronic obstructive pulmonary disease, and acute coronary syndrome (ACS). Here, CCL2 is linked to stroke disorder.